NCT05814926View on ClinicalTrials.gov

GP681 in Volunteers With Hepatic Impairment Compared With Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 26, 2023

Primary Completion Date

August 3, 2023

Study Completion Date

October 20, 2023

Conditions
Healthy VolunteersHepatic Impairment
Interventions
DRUG

GP681

GP681, tablet, oral

Trial Locations (1)

100069

Beijing You'an Hospital, Beijing Medical University, Beijing

Sponsors
All Listed Sponsors
lead

Jiangxi Qingfeng Pharmaceutical Co. Ltd.

INDUSTRY